Percivia | 503 followers on LinkedIn. PERCIVIA is a venture formed by Crucell N.V. and Royal DSM N.V., to develop recombinant therapeutic proteins using the PER.C6® human cell line, with a focus on biosimilar monoclonal antibodies globally. Additionally, PERCIVIA out-licenses the PER.C6® cell line and provides logistical support by training and advising on the methods of recombinant protein production using the technology to licensees. PERCIVIA’s unique advantage lies in the core technologies of PER.C6®, the company’s high yield proprietary human cell line, which enables SCALE™, a market-optimized manufacturing process, allowing for rapid facility set up with an “In Market, For Market”™ manufacturing solution.
Looking for a particular Percivia employee's phone or email?
Percivia Questions
The Percivia annual revenue was $6.6 million in 2026.
1 people are employed at Percivia.
Percivia is based in Cambridge, Massachusetts.
The NAICS codes for Percivia are [325, 3254, 541, 54, 32].
The SIC codes for Percivia are [873, 87, 28, 283].
Top Percivia Employees
Related Companies
